184 related articles for article (PubMed ID: 3538736)
1. Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.
Pisu E; Lombardi A; De Benedictis D; Bozzo C; Chiara E; Baggiore C; Bruno A; Cravero L; Pagano G; Lenti G
Acta Diabetol Lat; 1986; 23(3):215-25. PubMed ID: 3538736
[TBL] [Abstract][Full Text] [Related]
2. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
[TBL] [Abstract][Full Text] [Related]
3. [Insulin resistance and insulin secretion in type II non-obese diabetics].
Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
[TBL] [Abstract][Full Text] [Related]
4. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity.
Yoshinaga H; Kosaka K
Diabetes Res Clin Pract; 1999 May; 44(2):129-36. PubMed ID: 10414932
[TBL] [Abstract][Full Text] [Related]
6. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.
Lewy VD; Danadian K; Witchel SF; Arslanian S
J Pediatr; 2001 Jan; 138(1):38-44. PubMed ID: 11148510
[TBL] [Abstract][Full Text] [Related]
7. Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
Efendic S; Karlander S; Vranic M
J Clin Invest; 1988 Jun; 81(6):1953-61. PubMed ID: 3290257
[TBL] [Abstract][Full Text] [Related]
8. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
9. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
[TBL] [Abstract][Full Text] [Related]
11. Insulin clamp-derived measurements of insulin sensitivity and insulin secretion in lean and obese asian type 2 diabetic patients.
Suraamornkul S; Kwancharoen R; Ovartlarnporn M; Rawdaree P; Bajaj M
Metab Syndr Relat Disord; 2010 Apr; 8(2):113-8. PubMed ID: 20059360
[TBL] [Abstract][Full Text] [Related]
12. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D
J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus.
Hother-Nielsen O; Beck-Nielsen H
Acta Endocrinol (Copenh); 1991 Jun; 124(6):637-45. PubMed ID: 2068893
[TBL] [Abstract][Full Text] [Related]
14. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
Meneilly GS; Elliott T
Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
[TBL] [Abstract][Full Text] [Related]
15. The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.
Duman BS; Turkoglu C; Gunay D; Cagatay P; Demiroglu C; Buyukdevrim AS
Diabetes Nutr Metab; 2003 Aug; 16(4):243-50. PubMed ID: 14768774
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect.
Cavallo-Perin P; Cassader M; Bozzo C; Bruno A; Nuccio P; Dall'Omo AM; Marucci M; Pagano G
J Clin Invest; 1985 May; 75(5):1659-65. PubMed ID: 3889056
[TBL] [Abstract][Full Text] [Related]
17. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
19. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
20. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
Kolterman OG; Gray RS; Griffin J; Burstein P; Insel J; Scarlett JA; Olefsky JM
J Clin Invest; 1981 Oct; 68(4):957-69. PubMed ID: 7287908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
